ArticleLeukemia2017
High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients.
J Pan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
141 papers cite itlatest 60 shown
this paperpooled ittrialcites it